Switching Semaglutide to Tirzepatide: Dose Guide

How do you switch from semaglutide to tirzepatide?

Switching semaglutide to tirzepatide means restarting titration on the new drug, not converting your dose. There is no FDA-approved 1:1 conversion. Most prescribers start tirzepatide at 2.5 mg once weekly about one week after your last semaglutide dose, then titrate up. The two drugs act on different receptors and are not milligram-for-milligram equivalent.

Switching between semaglutide and tirzepatide at a glance

• There is no FDA-approved dose conversion in either direction. Any table you see is clinical-practice guidance, not an official equivalence.
• The most dangerous mistake is matching by number: assuming 2.4 mg of semaglutide equals 2.5 mg of tirzepatide. It does not, and it causes appetite to return.
• Most prescribers restart at the lowest dose of the new drug regardless of where you were on the old one.
• Timing is simple: start the new drug on your next scheduled weekly injection day, roughly one week after the last dose of the old one.
• Semaglutide acts on one receptor. Tirzepatide acts on two. That difference is why the doses are not comparable.
• Expect mild gastrointestinal side effects to return for a few weeks, as if you were starting fresh.
• Switching is always a prescriber decision. Never self-convert.

Why is there no direct dose conversion?

The reason semaglutide to tirzepatide has no clean conversion is that the two drugs are not the same kind of drug. Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GIP and GLP-1 receptor agonist. Activating two receptor pathways is not the same as activating one at a higher number, so their potencies do not line up on a milligram scale.

The semaglutide to tirzepatide dose ranges make the point on their own. Semaglutide for weight management tops out at 2.4 mg weekly. Tirzepatide runs from 2.5 mg to 15 mg weekly. A patient at the ceiling of one drug is nowhere near the ceiling of the other, and the raw numbers cannot be compared.

This is why every credible source describes a semaglutide to tirzepatide switch as re-initiation rather than conversion. There is no official crosswalk because the science does not support one.

The clinical-practice equivalence table

Prescribers still need a semaglutide to tirzepatide starting point, so clinical practice has produced approximate equivalences from trial data and prescribing experience. Read the header carefully: these are not a conversion formula, and no head-to-head dosing trial produced them.

Source: Approximate equivalences reported across clinical practice literature, 2026. These reflect prescribing patterns, not an FDA-approved conversion or a head-to-head dosing trial. Your prescriber decides your actual starting dose.

Note the semaglutide to tirzepatide gap between the two right-hand columns. The middle column shows where your prior exposure roughly maps. The right column shows where a cautious prescriber actually starts you, which is usually lower. Starting low and titrating up is safer than trying to match your old receptor activation on day one.

What is the most common switching mistake?

The single most common semaglutide to tirzepatide error is matching by number. A patient at 2.4 mg of semaglutide reasons that 2.5 mg of tirzepatide is “basically the same dose” and asks to start there. The number looks right. The pharmacology is not.

Here is what actually happens. Someone who spent months building tolerance at 2.4 mg of semaglutide has considerable GLP-1 receptor activation on board. Tirzepatide 2.5 mg is the lowest starting dose, designed for a drug-naive patient. Dropping to it can deliver substantially less appetite suppression than the person is used to. Within two to three weeks appetite returns, and some people regain a few pounds before they titrate up to an effective dose.

This is why the semaglutide to tirzepatide equivalence table exists and why it maps 2.4 mg of semaglutide to roughly 10 to 15 mg of tirzepatide, not to 2.5 mg. The mistake is understandable, and it is exactly why switching belongs to a prescriber and not to arithmetic.

How to switch from semaglutide to tirzepatide, step by step

The semaglutide to tirzepatide switch runs in seven steps.

1. Talk to your prescriber. Bring your current dose, how long you have been on it, how well you tolerate it, and why you want to switch.
2. Finish your current semaglutide cycle. Take your last semaglutide dose on its normal schedule. Do not stop early and do not double up.
3. Wait about one week. Start tirzepatide on what would have been your next weekly semaglutide injection day. The roughly seven-day gap matches the weekly dosing interval.
4. Start at the dose your prescriber sets, usually 2.5 mg or 5 mg. Even coming off maximum semaglutide, most people begin low.
5. Titrate by 2.5 mg, no sooner than every four weeks, up to a 15 mg maximum. Read the full ladder in the tirzepatide dosage chart.
6. Expect a short return of gastrointestinal side effects. Your gut is adapting to a new molecule. It usually settles within a few weeks.
7. Stay in contact. Report tolerability and results so your prescriber can adjust the pace.

The tirzepatide dosage chart has the full titration ladder, and tirzepatide units vs mg explains how to draw your new dose if you are on a compounded vial.

How do you switch from tirzepatide to semaglutide?

The same logic runs in reverse. There is no milligram-for-milligram equivalence going from tirzepatide to semaglutide either, just as there is none going from semaglutide to tirzepatide, and the standard approach is to restart at the beginning of the semaglutide titration schedule regardless of your tirzepatide dose.

Practically, that usually means starting semaglutide at 0.25 mg weekly and climbing on the normal schedule. Some prescribers move a patient with excellent GLP-1 tolerance through the early steps faster, but the decision is theirs, based on your history.

Reasons to switch this direction vary: cost, tolerability, supply, or a preference for a single-receptor agent. The semaglutide dosing schedule covers the ladder you would restart on.

Is tirzepatide stronger than semaglutide?

This is the question behind most semaglutide to tirzepatide switches. In head-to-head data, tirzepatide produced greater average weight loss. The SURMOUNT-1 trial reported mean weight reduction of about 21 percent at the highest tirzepatide dose over 72 weeks, while semaglutide weight-management trials reported roughly 15 percent. A direct comparison trial, SURMOUNT-5, compared the two agents in obesity and also favored tirzepatide on weight loss.

That does not make tirzepatide the right choice for everyone. Greater average weight loss comes with a gastrointestinal side effect burden that is at least as high, and the best drug is the one you tolerate and can sustain. Plateauing on semaglutide is one common, legitimate reason to consider the switch.

If you have stalled, the switch is one option among several. Read why weight loss plateaus on a GLP-1 before assuming a new drug is the answer.

What to expect in the first month after switching

Treat the semaglutide to tirzepatide switch like a fresh start, because pharmacologically it is one.

Frequently asked questions about switching semaglutide to tirzepatide

Is there a semaglutide to tirzepatide conversion chart?

Not an official one. The FDA has not approved a dose conversion between the two drugs. Clinical-practice tables exist, but they are approximate guidance, not a formula.

What tirzepatide dose equals 2.4 mg of semaglutide?

There is no exact semaglutide to tirzepatide equivalent. Clinical practice maps 2.4 mg of semaglutide to roughly 10 to 15 mg of tirzepatide, but most prescribers still re-initiate at 2.5 mg or 5 mg and titrate up.

Can I start tirzepatide at 2.5 mg if I was on max semaglutide?

You can, and many prescribers do, but be aware it may deliver less appetite suppression than you are used to for a few weeks until you titrate up.

How long should I wait between the two drugs?

About one week. Start the new drug on what would have been your next weekly injection day.

Will I regain weight when I switch?

Some people see a small, temporary regain if the new starting dose is less potent than their old one. It typically reverses as you titrate up.

Do side effects come back when switching?

Usually, mildly, for a few weeks. Your gut adapts to a new molecule the way it did the first time you started a GLP-1.

Is tirzepatide better than semaglutide?

On average it produces greater weight loss in trials, including the head-to-head SURMOUNT-5 study. Better for you depends on tolerability, cost, and your goals.

Can I switch from tirzepatide back to semaglutide?

Yes. Restart at the beginning of the semaglutide titration schedule regardless of your tirzepatide dose. Your prescriber sets the re-entry dose.

Can I switch between them repeatedly?

That is a clinical decision. Frequent switching is not a strategy. If you cannot settle, the answer is a conversation with your prescriber, not more switching.

Do I need a new prescription to switch?

Yes. A semaglutide to tirzepatide switch requires a new prescription, because each drug requires its own, and the switch requires a clinician to evaluate whether it is appropriate.

How do I convert my new dose into syringe units?

That depends on your compounded vial concentration in milligrams per milliliter. Never reuse your old drug’s unit math. Confirm with your pharmacy label and prescriber.

Is it safe to switch if I had bad nausea on semaglutide?

Tell your prescriber. A semaglutide to tirzepatide switch with a history of gastrointestinal intolerance raises the odds of similar issues, and you may need a slower titration.

Can I switch from compounded semaglutide to compounded tirzepatide?

Only under a prescriber’s direction. They are different molecules with different dosing and no valid milligram conversion between them.

Does switching reset my weight-loss progress?

No. Your progress stays. The semaglutide to tirzepatide switch changes the tool, not the results you have already achieved, though the first few weeks may feel like a reset while you titrate.

Thinking about switching?

A licensed U.S. clinician reviews your current medication, your history, and your goals, then decides whether switching is appropriate and where to restart you. No clinic visit. All 50 states. Compounded semaglutide is $129 per month. Compounded tirzepatide is $169 per month. No membership fees. No dose-escalation markups. Start your free online evaluation and a licensed U.S. clinician will review whether treatment is appropriate for you.

Free AHC calculators and tools

Every tool below is free, needs no account, and runs in your browser.

• Weight loss calculators hub — every AHC tool in one place
• BMI calculator — check where you sit against clinical eligibility thresholds
• Body fat calculator and visceral fat calculator — track composition, not just scale weight
• TDEE and macro calculator — set a calorie target that protects lean mass
• GLP-1 protein calculator — daily protein floor while appetite is suppressed
• Weight loss calculator and GLP-1 weight loss projection calculator — model a realistic timeline
• GLP-1 cost and savings calculator — compare cash pricing against brand-name retail

Medical Disclaimer

The content on this page is for general educational purposes only and does not create a doctor-patient relationship. Alternate Health Club is not a pharmacy and does not manufacture medications. Prescriptions are issued by independently contracted, U.S.-licensed clinicians who evaluate each patient individually, and every treatment decision, including whether any medication is appropriate, is made at the provider’s discretion. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or manufacturing quality. Individual results vary and no outcome is guaranteed. Brand names referenced on this page are trademarks of their respective owners and appear for educational context only. Always speak with a licensed healthcare provider before starting, stopping, or changing any medication.